Mitochondrial trifunctional protein deficiency: A severe fatty acid oxidation disorder with cardiac and neurologic involvement

M. E J Den Boer, Carlo Dionisi-Vici, Anupam Chakrapani, A. O J Van Thuijl, R. J A Wanders, Frits A. Wijburg

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Objective: To determine the spectrum of presentation, including both clinical and biochemical abnormalities, and the clinical course in a cohort of patients with complete mitochondrial trifunctional protein (MTP) deficiency, a rare inborn error of mitochondrial fatty acid oxidation. Study design: A questionnaire was sent to the referring physicians from 25 unselected MTP-deficient patients. Results: Twenty-one patients could be included. Questionnaires about four patients were not returned. Nine (43%) patients presented with rapidly progressive clinical deterioration; six (67%) of them had hypoketotic hypoglycemia. The remaining 12 patients presented with a much more insidious disease with nonspecific chronic symptoms, including hypotonia (100%), cardiomyopathy (73%), failure to thrive, or peripheral neuropathy. Ten patients (48%) presented in the neonatal period. Mortality was high (76%), mostly attributable to cardiac involvement. Two patients who were diagnosed prenatally died despite treatment. Conclusion: Complete MTP deficiency often presents with nonspecific symptomatology, which makes clinical recognition difficult. Hypotonia and cardiomyopathy are common presenting features, and the differential diagnosis of an infant with these signs should include MTP deficiency. In spite of early diagnosis and treatment, only a few patients with this condition have survived.

Original languageEnglish
Pages (from-to)684-689
Number of pages6
JournalJournal of Pediatrics
Volume142
Issue number6
DOIs
Publication statusPublished - Jun 1 2003

Fingerprint

Nervous System
Fatty Acids
Muscle Hypotonia
Cardiomyopathies
Mitochondrial Trifunctional Protein
Trifunctional Protein Deficiency With Myopathy And Neuropathy
Failure to Thrive
Peripheral Nervous System Diseases
Hypoglycemia
Early Diagnosis
Differential Diagnosis
Physicians
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Mitochondrial trifunctional protein deficiency : A severe fatty acid oxidation disorder with cardiac and neurologic involvement. / Den Boer, M. E J; Dionisi-Vici, Carlo; Chakrapani, Anupam; Van Thuijl, A. O J; Wanders, R. J A; Wijburg, Frits A.

In: Journal of Pediatrics, Vol. 142, No. 6, 01.06.2003, p. 684-689.

Research output: Contribution to journalArticle

Den Boer, M. E J ; Dionisi-Vici, Carlo ; Chakrapani, Anupam ; Van Thuijl, A. O J ; Wanders, R. J A ; Wijburg, Frits A. / Mitochondrial trifunctional protein deficiency : A severe fatty acid oxidation disorder with cardiac and neurologic involvement. In: Journal of Pediatrics. 2003 ; Vol. 142, No. 6. pp. 684-689.
@article{4ba93fa9883043679d1ce8c9429f26ea,
title = "Mitochondrial trifunctional protein deficiency: A severe fatty acid oxidation disorder with cardiac and neurologic involvement",
abstract = "Objective: To determine the spectrum of presentation, including both clinical and biochemical abnormalities, and the clinical course in a cohort of patients with complete mitochondrial trifunctional protein (MTP) deficiency, a rare inborn error of mitochondrial fatty acid oxidation. Study design: A questionnaire was sent to the referring physicians from 25 unselected MTP-deficient patients. Results: Twenty-one patients could be included. Questionnaires about four patients were not returned. Nine (43{\%}) patients presented with rapidly progressive clinical deterioration; six (67{\%}) of them had hypoketotic hypoglycemia. The remaining 12 patients presented with a much more insidious disease with nonspecific chronic symptoms, including hypotonia (100{\%}), cardiomyopathy (73{\%}), failure to thrive, or peripheral neuropathy. Ten patients (48{\%}) presented in the neonatal period. Mortality was high (76{\%}), mostly attributable to cardiac involvement. Two patients who were diagnosed prenatally died despite treatment. Conclusion: Complete MTP deficiency often presents with nonspecific symptomatology, which makes clinical recognition difficult. Hypotonia and cardiomyopathy are common presenting features, and the differential diagnosis of an infant with these signs should include MTP deficiency. In spite of early diagnosis and treatment, only a few patients with this condition have survived.",
author = "{Den Boer}, {M. E J} and Carlo Dionisi-Vici and Anupam Chakrapani and {Van Thuijl}, {A. O J} and Wanders, {R. J A} and Wijburg, {Frits A.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1067/mpd.2003.231",
language = "English",
volume = "142",
pages = "684--689",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Mitochondrial trifunctional protein deficiency

T2 - A severe fatty acid oxidation disorder with cardiac and neurologic involvement

AU - Den Boer, M. E J

AU - Dionisi-Vici, Carlo

AU - Chakrapani, Anupam

AU - Van Thuijl, A. O J

AU - Wanders, R. J A

AU - Wijburg, Frits A.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Objective: To determine the spectrum of presentation, including both clinical and biochemical abnormalities, and the clinical course in a cohort of patients with complete mitochondrial trifunctional protein (MTP) deficiency, a rare inborn error of mitochondrial fatty acid oxidation. Study design: A questionnaire was sent to the referring physicians from 25 unselected MTP-deficient patients. Results: Twenty-one patients could be included. Questionnaires about four patients were not returned. Nine (43%) patients presented with rapidly progressive clinical deterioration; six (67%) of them had hypoketotic hypoglycemia. The remaining 12 patients presented with a much more insidious disease with nonspecific chronic symptoms, including hypotonia (100%), cardiomyopathy (73%), failure to thrive, or peripheral neuropathy. Ten patients (48%) presented in the neonatal period. Mortality was high (76%), mostly attributable to cardiac involvement. Two patients who were diagnosed prenatally died despite treatment. Conclusion: Complete MTP deficiency often presents with nonspecific symptomatology, which makes clinical recognition difficult. Hypotonia and cardiomyopathy are common presenting features, and the differential diagnosis of an infant with these signs should include MTP deficiency. In spite of early diagnosis and treatment, only a few patients with this condition have survived.

AB - Objective: To determine the spectrum of presentation, including both clinical and biochemical abnormalities, and the clinical course in a cohort of patients with complete mitochondrial trifunctional protein (MTP) deficiency, a rare inborn error of mitochondrial fatty acid oxidation. Study design: A questionnaire was sent to the referring physicians from 25 unselected MTP-deficient patients. Results: Twenty-one patients could be included. Questionnaires about four patients were not returned. Nine (43%) patients presented with rapidly progressive clinical deterioration; six (67%) of them had hypoketotic hypoglycemia. The remaining 12 patients presented with a much more insidious disease with nonspecific chronic symptoms, including hypotonia (100%), cardiomyopathy (73%), failure to thrive, or peripheral neuropathy. Ten patients (48%) presented in the neonatal period. Mortality was high (76%), mostly attributable to cardiac involvement. Two patients who were diagnosed prenatally died despite treatment. Conclusion: Complete MTP deficiency often presents with nonspecific symptomatology, which makes clinical recognition difficult. Hypotonia and cardiomyopathy are common presenting features, and the differential diagnosis of an infant with these signs should include MTP deficiency. In spite of early diagnosis and treatment, only a few patients with this condition have survived.

UR - http://www.scopus.com/inward/record.url?scp=0038132933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038132933&partnerID=8YFLogxK

U2 - 10.1067/mpd.2003.231

DO - 10.1067/mpd.2003.231

M3 - Article

C2 - 12838198

AN - SCOPUS:0038132933

VL - 142

SP - 684

EP - 689

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -